alanine has been researched along with zanamivir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fornabaio, M; Kellogg, GE; Moscona, A; Porotto, M | 1 |
| Dong, R; Liu, G; Lu, Q; Peng, L; Tian, G; Wang, J; Yang, J; Zhou, L | 1 |
2 other study(ies) available for alanine and zanamivir
| Article | Year |
|---|---|
A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
Topics: Alanine; Animals; Binding Sites; Cell Line; Chlorocebus aethiops; Dimerization; HN Protein; Humans; Ligands; Models, Molecular; Mutation; Naphthalenes; Neuraminidase; Parainfluenza Virus 3, Human; Protein Structure, Quaternary; Receptors, Virus; Virus Internalization; Zanamivir | 2007 |
Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Drug Evaluation, Preclinical; Host-Pathogen Interactions; Humans; Molecular Docking Simulation; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Zanamivir | 2020 |